Showing 34,667 results

New & experimental HIV treatments

Gilead Sciences Announces FDA Approval of Odefsey as HIV-1 Treatment in Certain Patients

Editor's pick
Gilead press release
2 March 2016
Epidemiology & behaviour

Black gay men reject ‘lifetime HIV risk estimate’ in new CDC report

Editor's pick
Georgia Voice
2 March 2016
Retention & linkage to care

Rate of entry into HIV care improved by personalised counselling

News
1 March 2016
Harm reduction

Rehabs' Failure to Give Lifesaving Naloxone to Vulnerable Clients Is Unacceptable

Editor's pick
Truth Out
1 March 2016
PrEP

HIV Mystery: Solved?

Editor's pick
The Nation
1 March 2016
Retention & linkage to care

Studies probe retention in HIV care for women who start antiretroviral treatment during pregnancy

News
1 March 2016
Vaginal rings & topical PrEP

Vaginal ring for HIV prevention: a few details would have elevated good coverage to great

Editor's pick
Health News Review
1 March 2016
Vaginal rings & topical PrEP

Why a new vaginal ring could be a game-changer in HIV prevention

Editor's pick
The Conversation
1 March 2016
Exposure to HIV through medical procedures

Cambodia: ‘No HIV outbreak’ in Kandal village, say WHO, local authorities

Editor's pick
Phnom Penh Post
1 March 2016
Money

Calls for DWP staff training to recognise the fluctuating nature of HIV

Editor's pick
The National
1 March 2016
Social & legal issues

Africans tolerant on religion, ethnicity, nationality, and HIV, but not homosexuality, survey finds

Editor's pick
The South African
1 March 2016
Improving HIV care

CROI 2016: HIV trial data raises the question of how to end an epidemic when men are “missing but in action...”

Editor's pick
Science Speaks
1 March 2016
Harm reduction

Street heroin: Optimal preparation and injection

Editor's pick
Jon Derricott / YouTube
1 March 2016
Harm reduction

Liz Evans And InSite’s Insightful Story

Editor's pick
Medium
1 March 2016
PrEP

What People are Saying About Approval Of PrEP in Canada

Editor's pick
Positive Lite
1 March 2016
Finance & funding

Investing in prevention: is it cost-effective?

Editor's pick
Public Health England
1 March 2016
Conference announcements & declarations

Really Rapid Review — CROI 2016, Boston

Editor's pick
NEJM Journal Watch
1 March 2016
PrEP

Canada Approves Drug That Stops HIV Transmission, but It’s Still Really Expensive

Editor's pick
Vice
29 February 2016
The search for a cure

Experimental TLR7 agonist suppresses HIV-like virus in monkeys after ART interruption

News
29 February 2016
Epidemiology

Your lifetime risk of HIV by race, state and sexual preference — in four simple charts

Editor's pick
Washington Post
29 February 2016
Access to healthcare

His Job Is to Sell a $1,000 Pill for $10 Without Losing Money

Editor's pick
Bloomberg
29 February 2016
Cancer

Study does not support routine HPV quadrivalent vaccination to protect against anal cancer in older people living with HIV

News
29 February 2016
PrEP science

‘On-demand’ rectal microbicide gel has reasonable tolerability and acceptability – daily less so

News
28 February 2016
Treatment outcomes & life expectancy

Life expectancy in HIV-positive people in the US still lags 13 years behind HIV-negative people

News
28 February 2016